RTTNews | Oct 7, 2021 09:23AM EDT

09:23 Thursday, October 7, 2021 (RTTNews) - Cogent Presents New Data Showing Bezuclastinib As Differentiated KIT Inhibitor With Minimal Brain Penetration

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved